Recent Blog Posts

View Post: New HPV Vaccine Might Stop Vulvar Cancer in its Tracks
EmpowHer ...
4 Nov 2009 by hernews   ...
View Blog: http://www.empowher.com/

---

View Post: My Blog: Different HPV Vaccine Might Stop Vulvar Cancer in its Tracks
5 Nov 2009 by mitchsmom  
Different HPV Vaccine Might Stop Vulvar Cancer in its Tracks · New HPV Vaccine Might Stop Vulvar Cancer in its Tracks Working differently than Gardasil, Cervarix, it targets inside of virus, study shows. Posted by mitchsmom at 9:10 AM ...
View Blog: My Blog - http://mitchsmom.blogspot.com/

---

View Post: What is Vulvar Cancer? - Types of Vulvar Cancer, Vulvar Cancer ...
23 Oct 2009 by admin  
Vulvar cancer may be treated as a rare type of cancer which affects the external part of the female genitals organ called vagina. As it is a slowly growing cancer, it takes several years to show up the symptoms. Vulva is the external ...
View Blog: Health & Lifestyle Updates - ygoy.com - http://www.ygoy.com/

---

View Post: Health News about New HPV Vaccine Might Stop Vulvar Cancer in its ...
4 Nov 2009 by admin  
Health News about ModernMedicine New HPV Vaccine Might Stop Vulvar Cancer in its Tracks US News & World Report WEDNESDAY, Nov. 4 (HealthDay News) -- A vaccine that targets human papillomavirus (HPV) is able to stop precancerous lesions ...
View Blog: NATURAL HEALTH LIFE SOURCE - http://healthlifesource.com/

---

View Post: New Drug for HPV Might be Effective in Curbing Vulvar Cancer ...
5 Nov 2009 by Tangaroa Snell  
If the results of the study, which are currently being analyzed, are confirmed, it will give the world a new way for dealing with precancerous vulvar tumours, a definite medical breakthrough. ...
View Blog: TopNews New Zealand - http://topnews.net.nz/

---

View Post: Cervical and Vulvar Cancer Risk in Relation to the Joint Effects ...
15 Jul 2008 by Hussain, SK, Madeleine, MM, Johnson, LG,...  
... was associated with either a supramultiplicative (TGCT/GGCC; IOR, 2.09; 95% CI, 0.98-4.46) or submultiplicative (TTCC/TGTC; IOR, 0.37; 95% CI, 0.16-0.85 or TGCT/TGCC; IOR, 0.37; 95% CI, 0.15-0.87) joint effect in vulvar cancer risk. ...
View Blog: Cancer Epidemiology Biomarkers & Prevention... - http://cebp.aacrjournals.org/

---